Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $1.6M | $1.2M | $1.2M | $2.5M | $671.2K | $553.1K | $515.4K |
| Cost of revenue | $322.8K | $54.3K | $1.6M | $1.4M | $961.0K | $0 | $0 | $0 |
| Gross profit | $1.7M | $1.6M | −$406.2K | −$130.1K | $1.5M | $671.2K | $553.1K | $515.4K |
| Gross margin | 83.8% | 96.6% | -34.3% | -10.5% | 60.7% | 100.0% | 100.0% | 100.0% |
| R&D | $7.1M | $5.8M | $2.4M | $1.3M | $3.6M | $2.1M | $1.1M | $2.8M |
| Operating income | −$15.4M | −$12.8M | −$5.1M | −$4.5M | −$3.8M | −$3.6M | −$2.1M | −$1.5M |
| EBITDA | −$12.4M | −$11.1M | −$3.7M | −$4.2M | −$2.7M | −$2.7M | −$1.7M | −$2.6M |
| Net income | −$13.8M | −$12.9M | −$8.8M | −$1.3M | −$3.7M | −$3.6M | −$2.0M | −$3.6M |
| Net margin | -693.1% | -796.3% | -744.7% | -101.8% | -148.8% | -531.4% | -367.4% | -698.6% |
| EPS (diluted) | -0.40 | -0.32 | -0.21 | -0.04 | -0.09 | -0.08 | -0.06 | -0.11 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds DGCRF.
No tracked institution reports a position in DGCRF as of their last filing.
No one on the platform has traded DGCRF yet.
| $11973 |
| — |
| NLBSNutraLife BioSciences, Inc. | $0.00 | — | $17662 | — |
| NMMCFNMC Health plc | $0.00 | +0.00% | $2087 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.